2022
DOI: 10.1172/jci160326
|View full text |Cite
|
Sign up to set email alerts
|

Lipid balance must be just right to prevent development of severe liver damage

Abstract: Nonalcoholic fatty liver disease (NAFLD) is a major health concern that often associates with obesity and diabetes. Fatty liver is usually a benign condition, yet a fraction of individuals progress to severe forms of liver damage, including nonalcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC). Elevated sterol regulatory element–binding protein–driven (SREBP-driven) hepatocyte lipid synthesis is associated with NAFLD in humans and mice. In this issue of the JCI , Kawamur… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 16 publications
0
4
0
Order By: Relevance
“…The liver is considered the critical organ for fatty acid metabolism . SREBPs are activators of the complete liver cholesterol and fatty acid synthesis program. , Moreover, it is essential to note that the lipogenic enzymes acetyl-CoA carboxylase-1 (ACC1) and stearoyl-CoA desaturase-1 (SCD-1) are regulated by SREBPs . The ACBP is a vital lipid transport protein synthesizing intracellular lipids .…”
Section: Discussionmentioning
confidence: 99%
“…The liver is considered the critical organ for fatty acid metabolism . SREBPs are activators of the complete liver cholesterol and fatty acid synthesis program. , Moreover, it is essential to note that the lipogenic enzymes acetyl-CoA carboxylase-1 (ACC1) and stearoyl-CoA desaturase-1 (SCD-1) are regulated by SREBPs . The ACBP is a vital lipid transport protein synthesizing intracellular lipids .…”
Section: Discussionmentioning
confidence: 99%
“…GSK3 promotes the degradation of mature SREBP-1c ( Cross et al, 1995 ), which mediates lipid metabolism ( Lagathu et al, 2006 ). SREBP-1c is a major regulator of fatty acid synthesis in the liver ( Osborne and Espenshade, 2022 ). It can control the amount of TG in vivo by regulating acetyl coenzyme A carboxylase 1 (ACC1), fatty acid synthase (FASN), stearoyl coenzyme A desaturase (SCD-1) and other enzymes or proteins related to fatty acid synthesis ( Wang et al, 2015 ).…”
Section: Discussionmentioning
confidence: 99%
“…SREBP1, a member of sterol regulatory element−binding proteins (SREBPs), regulates lipogenesis as main transcription factors in mammals. 26 Previous studies have shown that SREBP1 regulated transcription of genes involved in fatty acid metabolism (FADS2, SCD1, and FASN). 27−29 Cellular immunofluorescence of SREBP1 nuclear localization also revealed that DHA treatment significantly reduced SREBP1 occupancy in the nucleus (Figure 5H and Figure S4G).…”
Section: Dha Regulates the Transcription Of Lipid Metabolism-related ...mentioning
confidence: 99%